As well as investigating the effects of psilocybin therapy for individuals with palliative care needs, we will also be conducting qualitative research into their experiences. Members of our project team have previously conducted similar research: nature.com/articles/s4159…

Longitudinal experiences of Canadians receiving compassionate access to psilocybin-assisted psychotherapy: nature.com/articles/s4159… Research on psilocybin therapy for individuals with life-threatening conditions has been conducted & remains underway in Canada.

Over the weekend PsyPal was presented at the Hopkins-Oxford Psychedelic Ethics (HOPE) Summit in Washington, D.C. by Tadeusz Hawrot linkedin.com/posts/tadeusz-…

link.springer.com/article/10.100… A recent review article gives an overview of many psychedelic substances, including psilocybin, and highlights common concerns in the research field. PsyPal hopes to start filling this research gap for individuals with end-of-life distress.

📢 Come work with us as a post-doc for spiritual care and psychedelic treatment! 🏢 University of Groningen, the Netherlands rug.nl/about-ug/work-…

euronews.com/health/2024/09… Members of the PsyPal consortium, Ulf Bremberg and Tadeusz Hawrot, spoke on the current state of psychedelic research in Europe. More information on PsyPal is available here: palliativeprojects.eu/psypal/

The PsyPal Project project was recently highlighted at the Hopkins-Oxford Psychedelic Ethics (HOPE) Summit in Washington, D.C, and represented by Tadeusz Hawrot of PAREA @pareascience.bsky.social. Read more about the event here: palliativeprojects.eu/psypal/2024/10…

" The development of guidelines will be essential to encourage wider therapy deployment." What do health professionals think about implementing psilocybin-assisted therapy in palliative care for existential distress? A World Café qualitative study: cambridge.org/core/journals/…

Among other topics Drug Science have produced, they released a podcast episode on research in psychedelics within palliative care with Dr Margaret Ross in 2021: drugscience.org.uk/podcast/episod… We are keen to contribute to this growing field in PsyPal!

Delighted that PsyPal's own Robert Schoevers delivered a talk called 'Introducing Psychedelic Therapy' during Norrsken Impact Week! This Norrsken event featured many innovators and experts seeking to address core problems in today's society Norrsken Mind Norrsken

A systematic review from PsyPal partners notes reporting issues for psychological interventions in psychedelic-assisted therapy trials. This aims to guide researchers in enhancing study quality: thelancet.com/journals/lanps…

PsyPal Press Release 17.12.24 This milestone marks a significant step forward for the first fully EU-funded study of psilocybin therapy in palliative care, set to begin recruiting patients in 2025: palliativeprojects.eu/psypal/2024/12…

We are excited to share new updates on our pathway to authorisation! See our newest press release available on our partners' websites and the official PsyPal site: palliativeprojects.eu/psypal/2024/12…

Have you read the newest PsyPal press release? We have exciting news regarding our pathway to authorisation and crucial clarity on what this means for the project. Read here for more: palliativeprojects.eu/psypal/2024/12…

Find out more about the project by regularly visiting our website: palliativeprojects.eu/psypal/about-p… From information on the different aspects of the project to information on our partners, stay informed of all things PsyPal here!

PsyPal is now posting on Bluesky! Be sure to join us over there to receive our social media updates on the project! bsky.app/profile/psypal…

news.ki.se/a-european-per… The Karolinska Institut will be running a series of webinars on psychedelic research in Europe, which may be of interest to our followers and supporters.